Viewing nowLinagliptin 5 mg (Linagliptin Besylate) Tablets
Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 202400697 · Approved 2024.03.29 · Insurance code 648508280
Improvement in blood sugar control for type 2 diabetes
This medication helps patients with type 2 diabetes to manage their blood sugar levels more effectively. It is more effective when used in conjunction with dietary control and regular exercise. It can be used alone or in combination with other diabetes medications. This helps to maintain stable blood sugar levels and contributes to the prevention of complications. Therefore, it is used for blood sugar control in patients with type 2 diabetes.
The recommended dosage of this medication is 5 mg of Linagliptin once daily (6.67 mg of Linagliptin Besylate). It can be taken regardless of meals. When used in combination with insulin or insulin secretagogues (such as sulfonylureas), lower doses of insulin and insulin secretagogues may be required to minimize the risk of hypoglycemia.
This medication should not be used by patients who are allergic to the active ingredient or any other components. This medication is not administered to patients with type 1 diabetes or diabetic ketoacidosis. Caution should be exercised when used in conjunction with insulin or sulfonylureas, which can cause hypoglycemia, as it may increase the risk of hypoglycemia. In patients with mild to moderate heart failure, this medication should be used with caution, and it is not recommended for patients with severe heart failure. Acute pancreatitis may occur, so if severe abdominal pain develops, the use of this medication should be stopped immediately and a consultation with a physician is advised. During therapy with this medication, there may be a risk of developing blistering skin rashes; if such symptoms occur, the medication should be discontinued immediately and consultation with a specialist is necessary. Patients should be alert for signs of hypoglycemia while taking this medication, and appropriate measures should be taken if symptoms appear. Women who are pregnant or nursing should consult their doctor regarding the use of this medication. Safety and efficacy in children under 10 years of age and in pediatric adolescents aged 10 to under 17 years have not been sufficiently established, so it is not recommended for this age group. Elderly patients can use this medication without special dosage adjustments; however, they should follow their doctor's instructions based on their condition. Patients with kidney or liver function problems can generally use it without dosage adjustments, but should adhere to their physician's guidance. In cases of overdose, it is essential to visit a hospital immediately for appropriate treatment; generally, treatment consists of removing remaining medication from the gastrointestinal tract and monitoring symptoms. Keep this medication out of the reach of children, and be cautious not to transfer it into other containers as this can compromise quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is also advisable to store the medication at room temperature between 1°C and 30°C. Storing it this way maintains the medication's effectiveness and safety.
Pink, round, film-coated tablets
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLinagliptin Besylate 6.67mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.